v3.26.1
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Jul. 03, 2026
Equity [Abstract]  
Schedule of Allocation of Share-Based Compensation Expense

The following table sets forth the detailed allocation of the share-based compensation expense which was included in the Company’s condensed consolidated statements of operations:

Three Months Ended

 

Six Months Ended

(in thousands)

July 3, 2026

 

June 27, 2025

 

July 3, 2026

 

June 27, 2025

Cost of revenue

$

808

 

$

359

 

$

1,073

 

$

619

Research and development

 

761

 

 

831

 

 

1,828

 

 

2,019

Selling, general and administrative

 

5,715

 

 

4,466

 

 

9,947

 

 

8,035

Total

$

7,284

 

$

5,656

 

$

12,848

 

$

10,673

 

Schedule of Restricted Stock Units

(in thousands, except per share amounts)

Number of
Shares

 

Weighted Average
Grant-Date Fair
Value Per Share

Balance at December 31, 2025

 

4,135

 

$

10.36

Granted

 

1,723

 

 

8.99

Vested

 

(2,056)

 

 

10.30

Forfeited

 

(340)

 

 

10.03

Balance at July 3, 2026

 

3,462

 

$

9.75